Evidence-based dental management in the new era of sickle cell disease (September 2020 Article 3)
Click on star to add to your MyADA bookmarks.
Click on star to remove from your MyADA bookmarks.
- CE Credit(s):
-
1
- Member Price:
-
$5.00
- Retail Price:
-
$40.00
Description:
JADA September 2020
Background.
Sickle cell disease (SCD) is an emerging global health issue
with rapid progress in therapy especially since 2017. However, systematic
reviews found no clinical trials on dental treatment of SCD.
Key
Words. Sickle cell; systemic health; evidence-based dentistry;
caries risk; malocclusion; pulp necrosis; ischemia; osteomyelitis; mental nerve
neuropathy;
guidelines.
